Publications by authors named "Lurit Bepo"
Background: Minority racial and ethnic populations have the highest prevalence of type 2 diabetes mellitus but lower use of sodium-glucose co-transporter-2 inhibitors (SGLT2i) and glucagon-like peptide-1 receptor agonists (GLP1ra), novel medications that reduce morbidity and mortality. Observed disparities may be due to differences in insurance coverage, which have variable cost-sharing, prior authorization, and formulary restrictions that influence medication access.
Objective: To assess whether racial/ethnic differences in SGLT2i and GLP1ra use differ by payer.
Article Synopsis
- This text outlines a new clinic model called Heart Plus that combines Addiction Medicine and Cardiology to treat patients with stimulant-associated cardiomyopathy (SA-CMP).
- The approach uses contingency management to significantly improve outpatient care engagement and reduce emergency visits and hospital admissions among these patients.
- Participants experienced a decrease in stimulant use and were better positioned to access social support services, leading to improved overall health and well-being.
Rationale & Objective: Contaminated water and other fluids are increasingly recognized to be associated with health care-associated infections. We investigated an outbreak of Gram-negative bloodstream infections at 3 outpatient hemodialysis facilities.
Study Design: Matched case-control investigations.